Axcella Health Inc. – NASDAQ:AXLA

Add to watchlist

Market closed

Open in about 6 hours

+1042.43%

month

+1042.43%

quarter

+1004.68%

year

Market Cap	N/A
Enterprise value	7.84M

P/E	-0.28
EV/Sales	N/A
EV/EBITDA	-0.06
Price/Sales	N/A
Price/Book	5.48
PEG ratio	-0.02
EPS	-0.89

Revenue	N/A
EBITDA	-35.43M
Income	-50.02M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Axcella Health Inc. (NASDAQ:AXLA): Profit margin
Sep 2022	0	-18.58M
Dec 2022	0	-24.25M
Mar 2023	0	-3.76M
Jun 2023	0	-3.41M

Axcella Health Financials Estimate

Q Y

Axcella Health Inc. (NASDAQ:AXLA): Analyst Estimates
2025	0	-15.94M

Analysts Price target
Financials & Ratios estimates

Axcella Health Inc. (NASDAQ:AXLA): Debt to assets
Sep 2022	30788000	38.34M	124.53%
Dec 2022	18927000	14.76M	78%
Mar 2023	12765000	12.03M	94.3%
Jun 2023	9282000	11.54M	124.33%

Axcella Health Inc. (NASDAQ:AXLA): Cash Flow
Sep 2022	-18.52M	10.17M	-301K
Dec 2022	-15.53M	-19K	7.27M
Mar 2023	-5.10M	525K	-27K
Jun 2023	-3.65M	0	13.32B

Axcella Health alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Axcella Health Inc. (NASDAQ:AXLA): Employee count
Aug 2023	11
Sep 2023	11
Oct 2023	11
Nov 2023	11
Dec 2023	11
Jan 2024	11
Feb 2024	11
Mar 2024	11
Apr 2024	11
May 2024	11
Jun 2024	11
Jul 2024	11

Axcella Health
Hedge Funds Holdings Q1 2023

32.89% -60.45%

of AXLA is owned by hedge funds

18 -15

hedge funds hold AXLA stock

17.87M -31.26M

shares is hold by hedge funds

AXLA hedge funds holdings changes

Axcella Health
Insider Trading

Axcella Health Inc. (NASDAQ:AXLA): Insider trades (number of shares)
Period	Buy	Sel
Jun 2022	0	590
Sep 2022	0	547
Oct 2022	14042296	16000
Feb 2023	0	5221
Mar 2023	0	679

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	1 Mar 2023	KOZIEL MARGARET officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock	679	$0.58	$394
Sale	10 Feb 2023	FEHLNER PAUL officer: SVP & Chief Legal Officer officer: SVP & Chief Legal Offi..	Common Stock	5,221	$0.66	$3,446
Sale	19 Oct 2022	HINSHAW WILLIAM director, officer..	Common Stock	16,000	$1.56	$25,024
Purchase	13 Oct 2022	SOCIETE DES PRODUITS NESTLE S.A. 10 percent owner 10 percent owner	Common Stock	3,658,536	$1.64	$5,999,999
Purchase	13 Oct 2022	FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent o.. 10 percent owner	Common Stock	2,743,902	$1.64	$4,499,999
Purchase	13 Oct 2022	FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent o.. 10 percent owner	Common Stock	3,048,780	$1.64	$4,999,999
Purchase	13 Oct 2022	FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent o.. 10 percent owner	Common Stock	919,111	$1.64	$1,507,342
Purchase	13 Oct 2022	FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent o.. 10 percent owner	Common Stock	914,634	$1.64	$1,500,000
Purchase	13 Oct 2022	FLAGSHIP VENTURES FUND IV GENERAL PARTNER LLC 10 percent o.. 10 percent owner	Common Stock	2,757,333	$1.64	$4,522,026
Sale	6 Sep 2022	KOZIEL MARGARET officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock	547	$2.52	$1,378

AXLA insider trading transactions

Status	Patent	Filling date	Issue date
Grant	Grant Utility: Compositions for therapy and health containing amino acids with bitter taste Filling date: 19 Jun 2019 Issue date: 12 Apr 2022	19 Jun 2019	12 Apr 2022
Grant	Grant Utility: Amino acid compositions and methods for the treatment of liver diseases Filling date: 19 Dec 2017 Issue date: 28 Sep 2021	19 Dec 2017	28 Sep 2021
Application	Application COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASSEMIAS Filling date: 8 Jun 2021 Issue date: 23 Sep 2021	8 Jun 2021	23 Sep 2021
Application	Application COMPOSITIONS AND METHODS FOR THE TREATMENT OF FAT INFILTRATION IN MUSCLE Filling date: 2 Mar 2021 Issue date: 23 Sep 2021	2 Mar 2021	23 Sep 2021
Application	Application COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF FIBROSIS Filling date: 19 Jun 2019 Issue date: 9 Sep 2021	19 Jun 2019	9 Sep 2021
Application	Application COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF INSULIN RESISTANCE AND METABOLIC CONDITIONS Filling date: 19 Jun 2019 Issue date: 9 Sep 2021	19 Jun 2019	9 Sep 2021
Application	Application COMPOSITIONS AND METHODS FOR THE REDUCTION OR TREATMENT OF INFLAMMATION Filling date: 19 Jun 2019 Issue date: 26 Aug 2021	19 Jun 2019	26 Aug 2021
Grant	Grant Utility: Compositions and methods for the treatment of hemoglobinopathies and thalassemias Filling date: 19 Jun 2019 Issue date: 13 Jul 2021	19 Jun 2019	13 Jul 2021
Application	Application REDUCED VOLUME FORMULATIONS INCLUDING AMINO ACID ENTITIES Filling date: 9 Oct 2020 Issue date: 6 May 2021	9 Oct 2020	6 May 2021
Grant	Grant Utility: Compositions and methods for the treatment of fat infiltration in muscle Filling date: 7 Feb 2020 Issue date: 13 Apr 2021	7 Feb 2020	13 Apr 2021

Axcella Health
Earnings Call Transcripts

Quarter	Transcript
Q3 2022 1 Nov 2022	Q3 2022 Earnings Call Transcript
Q4 2021 30 Mar 2022	Q4 2021 Earnings Call Transcript
Q2 2021 31 Jul 2021	Q2 2021 Earnings Call Transcript
Q4 2020 17 Mar 2021	Q4 2020 Earnings Call Transcript

AXLA earnings call transcripts

Axcella Health
Executives

Insider	Age	Since	Compensation
Mr. William R. Hinshaw Jr. (1969) Pres, Chief Executive Officer & Director	56		$812,050
Mr. Laurent Chardonnet (1965) Consultant	60		$576,060

Axcella Health
Latest News

Sunday, 8 October 2023
08:00	3 Pharma Stocks to Dump Before the Damage Is Done	InvestorPlace
Wednesday, 20 September 2023
11:28	Beware! 3 Biotech Stocks Waving Massive Red Flags Right Now	InvestorPlace
Friday, 15 September 2023
11:17	Are Medical Stocks Lagging Axcella Health (AXLA) This Year?	Zacks Investment Research
09:01	Why Is Axcella Health (AXLA) Stock Down 24% Today?	InvestorPlace
Thursday, 31 August 2023
09:05	Why Is Axcella Health (AXLA) Stock Down 21% Today?	InvestorPlace
Wednesday, 30 August 2023
10:31	Axcella (AXLA) Up on Patent Grant for Long Covid Fatigue Drug	Zacks Investment Research
Tuesday, 29 August 2023
13:19	Why Is Axcella Health (AXLA) Stock Up 280% Today?	InvestorPlace
09:28	Axcella Health stock rockets on long Covid patent win	Proactive Investors
Tuesday, 22 August 2023
08:04	Why Is Axcella Health (AXLA) Stock Up 68% Today?	InvestorPlace
Thursday, 16 February 2023
07:35	Why Is Axcella Health (AXLA) Stock Up 35% Today?	InvestorPlace
Thursday, 26 January 2023
09:28	Penny Stocks To Buy Now? 7 To Watch With Big News this Week	PennyStocks
Wednesday, 25 January 2023
12:10	4 Penny Stocks To Watch With Big News This Week	PennyStocks
Tuesday, 24 January 2023
08:06	Why Is Axcella Health (AXLA) Stock Up 66% Today?	InvestorPlace
Tuesday, 20 December 2022
06:00	How to Find Undervalued Penny Stocks: Quick Guide	PennyStocks
Friday, 11 November 2022
11:18	Axcella Health Inc. (AXLA) Loses 47.9% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner	Zacks Investment Research
Thursday, 3 November 2022
09:59	Axcella to Present at the American Association for the Study of Liver Diseases (AASLD) Annual Meeting	Business Wire
Tuesday, 1 November 2022
11:54	Axcella Health Inc. (AXLA) Q3 2022 Earnings Call Transcript	Seeking Alpha
Thursday, 29 September 2022
07:51	Axcella's stock is up 10% after sharing new data for its NASH treatment	Market Watch
Tuesday, 9 August 2022
09:02	5 Biotech Stocks Likely to Outpace Q2 Earnings Estimates	Zacks Investment Research
Friday, 27 May 2022
12:03	Axcella (AXLA) Up on Decision to Prioritize Long-COVID Program	Zacks Investment Research
Wednesday, 30 March 2022
12:24	Axcella Health Inc. (AXLA) CEO Bill Hinshaw on Q4 2021 Results - Earnings Call Transcript	Seeking Alpha
Wednesday, 23 March 2022
07:02	Axcella to Report Fourth Quarter and Year End 2021 Financial Results on March 30, 2022	Business Wire
Thursday, 17 March 2022
08:41	Insiders Buy Over $7M Of 3 Penny Stocks	Benzinga
Monday, 14 February 2022
14:07	Axcella (AXLA) Announces Fast Track Designation For AXA1125	Pulse2
Thursday, 30 December 2021
11:29	Down 24% in 4 Weeks, Here's Why Axcella Health Inc. (AXLA) Looks Ripe for a Turnaround	Zacks Investment Research
Wednesday, 8 December 2021
11:22	Down 24.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Axcella Health Inc. (AXLA)	Zacks Investment Research
Monday, 15 November 2021
09:15	5 Winning Stocks Backed by the Overlooked Rising P/E Ratio	Zacks Investment Research
Wednesday, 10 November 2021
09:57	Is a Surprise Coming for Axcella Health (AXLA) This Earnings Season?	Zacks Investment Research
Tuesday, 26 October 2021
09:32	Axcella To Test NASH Candidate In Long COVID Patients	Benzinga
Tuesday, 28 September 2021
10:57	Axcella's Leading Drug Candidate for Overt Hepatic Encephalopathy Offers Hope in a Market Requiring Innovation	Benzinga

Frequently Asked Questions (FAQ)

When is Axcella Health's next earnings date?

Unfortunately, Axcella Health's (AXLA) next earnings date is currently unknown.
Does Axcella Health pay dividends?

No, Axcella Health does not pay dividends.
What is Axcella Health's stock symbol?

Axcella Health Inc. is traded on the NASDAQ under the ticker symbol "AXLA".
What is Axcella Health's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Axcella Health?

Shares of Axcella Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Axcella Health's key executives?
Axcella Health's management team includes the following people:
- Mr. William R. Hinshaw Jr. Pres, Chief Executive Officer & Director(age: 56, pay: $812,050)
- Mr. Laurent Chardonnet Consultant(age: 60, pay: $576,060)
How many employees does Axcella Health have?

As Jul 2024, Axcella Health employs 11 workers.
When Axcella Health went public?

Axcella Health Inc. is publicly traded company for more then 6 years since IPO on 9 May 2019.
What is Axcella Health's official website?

The official website for Axcella Health is axcellahealth.com.
Where are Axcella Health's headquarters?

Axcella Health is headquartered at 840 Memorial Drive, Cambridge, MA.
How can i contact Axcella Health?

Axcella Health's mailing address is 840 Memorial Drive, Cambridge, MA and company can be reached via phone at 857 320 2200.

Axcella Health Inc.

axcellahealth.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

857 320 2200

840 Memorial Drive
Cambridge, MA 02139

CIK: 0001633070
ISIN: US05454B2043
CUSIP: 05454B105